Drreddys Laboratories | RDY - Pre Tax Profit


Drreddys Laboratories reported INR15.43B in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Aurora Cannabis CAD 46.98M 66.36M Sep/2025
Bayer EUR -1.16B 735M Sep/2025
Canopy Growth CAD -1.42M 39.82M Sep/2025
Cipla INR 11.69B 6.85B Dec/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Drreddys Laboratories INR 15.43B 1.96B Dec/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lonza CHF 624M 197M Dec/2024
Novartis USD 4.2B 335M Sep/2025
Pacira USD -1.93M 10.63M Jun/2025
Prestige Brands USD 69.13M 7.35M Sep/2025
Richter Gedeon HUF 78.56B 32.66B Dec/2024
Sun Pharmaceuticals INR 41.68B 9.95B Sep/2025
Supernus Pharmaceuticals USD -57.95M 74.62M Sep/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025